ATE411816T1 - Zusammensetzungen gegen coccidiosis bei hühnern - Google Patents

Zusammensetzungen gegen coccidiosis bei hühnern

Info

Publication number
ATE411816T1
ATE411816T1 AT03736272T AT03736272T ATE411816T1 AT E411816 T1 ATE411816 T1 AT E411816T1 AT 03736272 T AT03736272 T AT 03736272T AT 03736272 T AT03736272 T AT 03736272T AT E411816 T1 ATE411816 T1 AT E411816T1
Authority
AT
Austria
Prior art keywords
chicken
coccidiosis
eimeria
composition
egg
Prior art date
Application number
AT03736272T
Other languages
English (en)
Inventor
Yoshikatsu Kodama
Hideaki Yokoyama
Sa Van Nguyen
Original Assignee
Ghen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ghen Corp filed Critical Ghen Corp
Application granted granted Critical
Publication of ATE411816T1 publication Critical patent/ATE411816T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39575—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from other living beings excluding bacteria and viruses, e.g. protozoa, fungi, plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Botany (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03736272T 2002-06-28 2003-06-26 Zusammensetzungen gegen coccidiosis bei hühnern ATE411816T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002189137A JP3995541B2 (ja) 2002-06-28 2002-06-28 抗鶏コクシジウム症組成物

Publications (1)

Publication Number Publication Date
ATE411816T1 true ATE411816T1 (de) 2008-11-15

Family

ID=29996838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03736272T ATE411816T1 (de) 2002-06-28 2003-06-26 Zusammensetzungen gegen coccidiosis bei hühnern

Country Status (10)

Country Link
US (1) US20060057150A1 (de)
EP (1) EP1552848B1 (de)
JP (1) JP3995541B2 (de)
KR (1) KR100617415B1 (de)
CN (1) CN1678349A (de)
AT (1) ATE411816T1 (de)
AU (1) AU2003243999A1 (de)
DE (1) DE60324299D1 (de)
TW (1) TW200410712A (de)
WO (1) WO2004002527A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004189672A (ja) * 2002-12-11 2004-07-08 Gen Corp:Kk 抗下痢症組成物
US8110188B2 (en) * 2003-03-18 2012-02-07 Investigacion Aplicada, S.A. De C.V. Compositions for prevention and treatment of infections caused by coccidia in chickens
JP2006036661A (ja) * 2004-07-23 2006-02-09 Gen Corp:Kk 歯周炎を治療又は予防するための組成物
CA2616561C (en) * 2005-07-25 2018-12-18 Avianax, Llc Therapeutic goose antibodies for treatment and prophylaxis of transmittable viral diseases
US8877187B2 (en) 2005-07-25 2014-11-04 Avianax, Llc Therapeutic antibodies for treatment and prophylaxis of transmittable viral diseases
CN101186647B (zh) * 2007-12-13 2010-04-21 成都乾坤动物药业有限公司 鸡球虫高免卵黄抗体的制备方法
JP2011016843A (ja) * 2010-10-13 2011-01-27 Gen Corp:Kk 歯周炎を治療又は予防するための組成物
WO2014022572A1 (en) * 2012-08-01 2014-02-06 Pacific Vet Group-Usa, Inc. Probiotic for amelioration of coccidiosis vaccine reaction
TWI463987B (zh) * 2012-09-17 2014-12-11 Univ Hungkuang 使用包含有４株乳酸菌菌株的混合物來預防和／或治療雞球蟲病
CN103554046B (zh) * 2013-11-08 2015-04-01 中国农业科学院上海兽医研究所 一种具有抗鸡球虫病的三嗪化合物
BR112016027335B1 (pt) 2014-05-23 2021-06-08 Phibro-Animal Health Corporation combinação, uso desta, método para produzir a referida combinação e composição formulada para administração a um animal
AR103086A1 (es) * 2014-12-17 2017-04-12 Nutrition Physiology Company Llc Composiciones y métodos para reducir las infecciones en aves de corral
WO2018131930A1 (ko) * 2017-01-12 2018-07-19 차장옥 콕시듐증 예방 또는 치료용 조성물, 이의 제조방법 및 이의 이용
BR112019016642A2 (pt) * 2017-02-13 2020-03-31 United States Of America, As Represented By The Secretary Of Agriculture Produto de ovo hiperimunizado para tratamento de enterite necrótica em aves
CN108553640A (zh) * 2018-06-13 2018-09-21 佛山市正典生物技术有限公司 一种鸡球虫病弱毒活疫苗及其制备方法和应用
WO2020018793A1 (en) * 2018-07-18 2020-01-23 University Of Connecticut Methods for enhancing poultry growth and performance
BE1028700B1 (nl) * 2020-10-13 2022-05-16 Poulpharm Bvba Werkwijze voor het testen van de efficiëntie van anti-parasitaire (coccidiose) middelen bij pluimvee en konijnen
CN115105518B (zh) * 2022-06-30 2023-08-18 广东省农业科学院作物研究所 马先蒿苷a在制备鸡饲料或者抗鸡球虫病的药物中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135073A3 (de) * 1983-08-19 1987-05-27 American Cyanamid Company Gegen Merozoiten von Eimeria Spp. reaktive monoklonale Antikörper und Antigene
CA1340520C (en) * 1984-06-05 1999-05-04 Karel Z. Newman Jr. Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix
US4724145A (en) * 1985-11-18 1988-02-09 Merck & Co., Inc. Eimeria acervulina immunogens
DE3689717T2 (de) * 1985-11-25 1994-10-20 Ghen Corp Einen spezifischen Antikörper enthaltender Stoff aus Eiern, Verfahren zu dessen Herstellung und seine Anwendung.
JPH0753669B2 (ja) * 1985-11-25 1995-06-07 株式会社ゲン・コーポレーション 鶏卵からの特異的抗体含有材料およびその製造方法と用途
JP2615673B2 (ja) * 1987-10-05 1997-06-04 株式会社ゲン・コーポレーション 食鳥の食中毒菌保菌抑制材料および食鳥肉の食中毒菌抑制方法
ZA893740B (en) * 1988-06-03 1990-02-28 Hoffmann La Roche Recombinant coccidiosis vaccines
JPH03151853A (ja) * 1989-11-09 1991-06-28 Kanebo Ltd 抗体およびそれを有効成分とする整腸食品
ZA9010461B (en) * 1990-01-26 1991-10-30 Hoffmann La Roche Recombinant coccidiosis vaccines-5-7 eimeria surface antigen
EP0706400A1 (de) * 1993-03-15 1996-04-17 Pharma Pacific Pty. Ltd. Therapeutische formulierung und verfahren
JP2738648B2 (ja) * 1994-03-18 1998-04-08 中部飼料株式会社 抗コクシジウム症用飼料添加物，飼料，治療剤，予防方法，治療方法
JPH0840935A (ja) * 1994-07-27 1996-02-13 Nisshin Flour Milling Co Ltd 家禽類のコクシジウム症に対して免疫を付与する方法
US5976580A (en) * 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
US5807551A (en) * 1996-04-01 1998-09-15 Iowa State University Research Foundation, Inc. Method to provide artificial passive immunity in birds
WO1998008540A1 (en) * 1996-08-28 1998-03-05 Ophidian Pharmaceuticals, Inc. Multivalent vaccine for clostridium botulinum neurotoxin
JPH10182483A (ja) * 1996-12-26 1998-07-07 Sumitomo Pharmaceut Co Ltd コクシジウム抗原及びコクシジウム症ワクチン
US6019985A (en) * 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
TWI348376B (en) * 2002-02-26 2011-09-11 Wyeth Corp Selection of poultry eimeria strains through extra-intestinal sporozites
US8110188B2 (en) * 2003-03-18 2012-02-07 Investigacion Aplicada, S.A. De C.V. Compositions for prevention and treatment of infections caused by coccidia in chickens

Also Published As

Publication number Publication date
KR100617415B1 (ko) 2006-08-30
WO2004002527A1 (ja) 2004-01-08
EP1552848B1 (de) 2008-10-22
TW200410712A (en) 2004-07-01
JP2004026775A (ja) 2004-01-29
AU2003243999A1 (en) 2004-01-19
EP1552848A1 (de) 2005-07-13
US20060057150A1 (en) 2006-03-16
EP1552848A4 (de) 2006-02-08
JP3995541B2 (ja) 2007-10-24
DE60324299D1 (de) 2008-12-04
KR20050024400A (ko) 2005-03-10
CN1678349A (zh) 2005-10-05

Similar Documents

Publication Publication Date Title
DE60324299D1 (de) Zusammensetzungen gegen coccidiosis bei hühnern
DK1147117T3 (da) Immunologiske adjuvansforbindelser
WO2003003941A3 (en) One dose vaccination with mycoplasma hyopneumoniae
EP2394658A3 (de) Passive Immunisierung gegen Clostridium difficile-Erkrankung
WO2003011223A3 (en) Immunomodulatory compounds and methods of use thereof
WO2006126981A3 (en) Compositions and methods for mucosal vaccination
UA41381C2 (uk) Спосіб вакцинації птиці in ovo проти кокцидіозу
WO2003024354A3 (en) Interleukin-12 as a veterinary vaccine adjuvant
Hirunpetcharat et al. Intranasal immunization with yeast‐expressed 19 kD carboxyl‐terminal fragment of Plasmodium yoelii merozoite surface protein‐1 (yMSP119) induces protective immunity to blood stage malaria infection in mice
WO2007140244A3 (en) Vaccination of young animals against lawsonia intracellularis infections
WO2004037175A3 (en) Compositions and methods for treating human papillomavirus-mediated disease
EA200800917A1 (ru) Адъюванты для вакцин
ATE201446T1 (de) Impfstoff gegen geflügelkokzidose
DE60031243D1 (de) Impfstofformulierung gegen tuberkulose mit monoglyceriden oder fettsäuren als adjuvant
TNSN08184A1 (en) Chimeric antigens and vaccines
ATE471156T1 (de) Antigene zusammensetzungen zur immunisierung nichtmenschlicher säuger gegen streptococcus equi
ATE454394T1 (de) Rekombinantes, 250 kda grosses antigen aus sporozoiten/merozoiten von eimeria maxima codierende nukleinsäuren und ihre verwendungen
WO2004043286A3 (en) Use of rmlt as a marker antigen for vaccines and as a synergistic adjuvant with amphigen
GT199600036A (es) Vacunacion in ovo contra la coccidiosis.
DE50210696D1 (de) Orale Vakzinierung mit nackten Tumor-Antigen-Mimotopen
TW200612982A (en) Vaccine composed of Mycoplasma hyopneumoniae and bacterial antigen and method for manufacturing thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties